CRDF
#4109
Cardiff Oncology, Inc. - Common Stock
0.9 4 USD
-0.05%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-5.05%
Monthly Change
+9.30%
6 month change
-50.26%
Year Change
-54.81%
Previous Close
0.9 9
Open
0.9 4
Low
0.9 4
High
0.9 4
Volume
7
Financials
- Market Capitalization 73.13 M
- Employee 31
- Founded 1999
- CEO Mark Erlander
- Website www.cardiffoncology.com
- Headquarter Delaware, United States
- FIGI BBG000PXLKM7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.07
Price to sales ratio
316.73
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4096 |  ELTX Elicio Therapeutics, Inc. - Common Stock | 2.84 USD | -5.33% | -7.19% | -4.05% | -71.60% | 74.64 M USD | ||
| 4106 |  ANVS Annovis Bio, Inc. Common Stock | 1.72 USD | -4.97% | -6.01% | -2.82% | -25.54% | 73.28 M USD | ||
| 4118 |  MNOV MediciNova, Inc. - Common Stock | 1.44 USD | +1.41% | +3.60% | +6.67% | +10.77% | 70.88 M USD | ||
| 4125 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.20 USD | -0.83% | -1.64% | 0.00% | -41.18% | 69.88 M USD |
Frequently asked questions about Cardiff Oncology, Inc. Common Stock
What is the Cardiff Oncology, Inc. Common Stock stock price today?
The current price of Cardiff Oncology, Inc. Common Stock (CRDF) is 0.94. Over the past 24 hours, the stock has changed by -5.05%. Follow the CRDF chart for real-time price dynamics.
What is the stock ticker of Cardiff Oncology, Inc. Common Stock?
Cardiff Oncology, Inc. Common Stock trades under the ticker CRDF. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cardiff Oncology, Inc. Common Stock stock going up?
CRDF has changed by +1.08% over the last week, +9.30% over the last month, and -54.81% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Cardiff Oncology, Inc. Common Stock?
Cardiff Oncology, Inc. Common Stock currently has a market capitalization of 73.13 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Cardiff Oncology, Inc. Common Stock earnings last quarter?
Last quarter, Cardiff Oncology, Inc. Common Stock reported earnings of -0.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Cardiff Oncology, Inc. Common Stock revenue for the last quarter?
Cardiff Oncology, Inc. Common Stock reported quarterly revenue of 104 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Cardiff Oncology, Inc. Common Stock net income for the last quarter?
Cardiff Oncology, Inc. Common Stock reported net income of -9.23 M for the last quarter. The previous quarter showed -12.35 M, which means net income changed by +25.22%.
How many employees does Cardiff Oncology, Inc. Common Stock have?
As of the latest available data, Cardiff Oncology, Inc. Common Stock has 31 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cardiff Oncology, Inc. Common Stock EBITDA?
Cardiff Oncology, Inc. Common Stock EBITDA is -9.53 M, and its EBITDA margin is -9 161.54%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cardiff Oncology, Inc. Common Stock stock?
You can buy Cardiff Oncology, Inc. Common Stock (CRDF) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cardiff Oncology, Inc. Common Stock stock?
Investing in Cardiff Oncology, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRDF chart and related analysis on metatrader.com as part of your research.